<DOC>
	<DOCNO>NCT00331825</DOCNO>
	<brief_summary>We initiate study research grant department health Taoyuan mental hospital choose risperidone olanzapine study medication . We compare incidence use anticholinergic drug schizophrenic patient Han ethnic neuroleptic-induced acute dystonia parkinsonism test hypothesis two medication different EPS incidence EPS intolerant population .</brief_summary>
	<brief_title>Risperidone Olanzapine Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia Parkinsonism</brief_title>
	<detailed_description>Objective : First generation antipsychotic frequently induce extrapyramidal side effect ( EPS ) . Second generation antipsychotic choice EPS intolerant schizophrenic patient . But one second generation antipsychotic good choice definitive result . We compare risperidone olanzapine schizophrenic patient acute dystonia parkinsonism side effect observe incidence need concomitant anticholinergic drug . We also collect data average dose risperidone olanzapine help dose strategy guideline EPS intolerant schizophrenic patient . Method : This randomize , rater-blind , parallel group , flexible dose study enrol patient Taoyuan Mental Hospital July 2000 July 2003 . Schizophrenia ( DSM-IV ) patient meet research criterion neuroleptic-induced acute dystonia parkinsonism research criterion DSM-IV great moderate severity ( ＞4 ) global impression extrapyramidal syndrome rating scale ( ESRS ) . 70 patient random assignment risperidone olanzapine 8 week . The primary outcome compare incidence concomitant anticholinergic drug .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Age 1865 y/o ; Female patient pregnancy plan must agree use reliable pregnancy prevention method childbearing age ; Meet schizophrenia criterion DSMIV ; Fulfill DSMIV neurolepticinduced acute dystonia parkinsonism research criterion , severity acute dystonia parkinsonism great moderate degree ( ＞4 ) assess global impression Extrapyramidal System Rating Scale ( item 43 44 ESRS ) ; Patients legal responsible people agree join study sign inform consent Had axis I diagnosis DSMIV ; Unstable major systemic disease ; Had neurological disorder influence EPS assessment ; Substance abuse dependence coffee tobacco within 6 month study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2000</verification_date>
	<keyword>Schizophrenia , EPS , risperidone , olanzapine</keyword>
</DOC>